Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Related Citations for PubMed (Select 23134735)

1.

Development and validation of a high-throughput intrinsic ATPase activity assay for the discovery of MEKK2 inhibitors.

Ahmad S, Hughes MA, Johnson GL, Scott JE.

J Biomol Screen. 2013 Apr;18(4):388-99. doi: 10.1177/1087057112466430. Epub 2012 Nov 7.

2.

Three mechanistically distinct kinase assays compared: Measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors.

Kashem MA, Nelson RM, Yingling JD, Pullen SS, Prokopowicz AS 3rd, Jones JW, Wolak JP, Rogers GR, Morelock MM, Snow RJ, Homon CA, Jakes S.

J Biomol Screen. 2007 Feb;12(1):70-83. Epub 2006 Dec 8.

PMID:
17166826
3.

Identification of MEKK2/3 serine phosphorylation site targeted by the Toll-like receptor and stress pathways.

Zhang D, Facchinetti V, Wang X, Huang Q, Qin J, Su B.

EMBO J. 2006 Jan 11;25(1):97-107. Epub 2005 Dec 15.

4.

Development of a high-throughput screening method for LIM kinase 1 using a luciferase-based assay of ATP consumption.

Mezna M, Wong AC, Ainger M, Scott RW, Hammonds T, Olson MF.

J Biomol Screen. 2012 Apr;17(4):460-8. doi: 10.1177/1087057111430529. Epub 2011 Dec 7.

5.

Identification by high-throughput screening of viridin analogs as biochemical and cell-based inhibitors of the cell cycle-regulated nek2 kinase.

Hayward DG, Newbatt Y, Pickard L, Byrne E, Mao G, Burns S, Sahota NK, Workman P, Collins I, Aherne W, Fry AM.

J Biomol Screen. 2010 Sep;15(8):918-27. doi: 10.1177/1087057110376537. Epub 2010 Jul 27.

6.

Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.

Comess KM, Sun C, Abad-Zapatero C, Goedken ER, Gum RJ, Borhani DW, Argiriadi M, Groebe DR, Jia Y, Clampit JE, Haasch DL, Smith HT, Wang S, Song D, Coen ML, Cloutier TE, Tang H, Cheng X, Quinn C, Liu B, Xin Z, Liu G, Fry EH, Stoll V, Ng TI, Banach D, Marcotte D, Burns DJ, Calderwood DJ, Hajduk PJ.

ACS Chem Biol. 2011 Mar 18;6(3):234-44. doi: 10.1021/cb1002619. Epub 2011 Jan 20.

PMID:
21090814
7.

A bioluminogenic HDAC activity assay: validation and screening.

Halley F, Reinshagen J, Ellinger B, Wolf M, Niles AL, Evans NJ, Kirkland TA, Wagner JM, Jung M, Gribbon P, Gul S.

J Biomol Screen. 2011 Dec;16(10):1227-35. doi: 10.1177/1087057111416004. Epub 2011 Aug 10.

PMID:
21832257
8.

A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).

Vainshtein I, Silveria S, Kaul P, Rouhani R, Eglen RM, Wang J.

J Biomol Screen. 2002 Dec;7(6):507-14.

PMID:
14599348
9.

Applying ligands profiling using multiple extended electron distribution based field templates and feature trees similarity searching in the discovery of new generation of urea-based antineoplastic kinase inhibitors.

Dokla EM, Mahmoud AH, Elsayed MS, El-Khatib AH, Linscheid MW, Abouzid KA.

PLoS One. 2012;7(11):e49284. doi: 10.1371/journal.pone.0049284. Epub 2012 Nov 20.

10.

High-yield production and characterization of biologically active GST-tagged human topoisomerase IIα protein in insect cells for the development of a high-throughput assay.

Singh PK, Chan PF, Hibbs MJ, Vazquez MJ, Segura DC, Thomas DA, Theobald AJ, Gallagher KT, Hassan NJ.

Protein Expr Purif. 2011 Apr;76(2):165-72. doi: 10.1016/j.pep.2010.08.001. Epub 2010 Aug 13.

PMID:
20709174
11.

Development of a high-throughput screening assay for the discovery of small-molecule SecA inhibitors.

Segers K, Klaassen H, Economou A, Chaltin P, Anné J.

Anal Biochem. 2011 Jun 15;413(2):90-6. doi: 10.1016/j.ab.2011.02.012. Epub 2011 Feb 19.

PMID:
21338570
12.

Discovery of diverse small molecule chemotypes with cell-based PKD1 inhibitory activity.

Sharlow ER, Mustata Wilson G, Close D, Leimgruber S, Tandon M, Reed RB, Shun TY, Wang QJ, Wipf P, Lazo JS.

PLoS One. 2011;6(10):e25134. doi: 10.1371/journal.pone.0025134. Epub 2011 Oct 5.

13.

Kinase inhibitor selectivity profiling using differential scanning fluorimetry.

Fedorov O, Niesen FH, Knapp S.

Methods Mol Biol. 2012;795:109-18. doi: 10.1007/978-1-61779-337-0_7.

PMID:
21960218
14.

Differential selectivity of JAK2 inhibitors in enzymatic and cellular settings.

Yu V, Pistillo J, Archibeque I, Han Lee J, Sun BC, Schenkel LB, Geuns-Meyer S, Liu L, Emkey R.

Exp Hematol. 2013 May;41(5):491-500. doi: 10.1016/j.exphem.2013.01.005. Epub 2013 Jan 19.

PMID:
23340136
15.

Development of high-throughput TR-FRET and AlphaScreen assays for identification of potent inhibitors of PDK1.

Xu Z, Nagashima K, Sun D, Rush T, Northrup A, Andersen JN, Kariv I, Bobkova EV.

J Biomol Screen. 2009 Dec;14(10):1257-62. doi: 10.1177/1087057109349356. Epub .

PMID:
19822882
16.
17.

EphB4 cellular kinase activity assayed using an enzymatic protein interaction system.

Wehrman T, Nguyen M, Feng W, Bader B.

Assay Drug Dev Technol. 2013 May;11(4):237-43. doi: 10.1089/adt.2012.490. Epub 2013 Apr 4.

PMID:
23557019
18.

Multiplex enzyme assays and inhibitor screening by mass spectrometry.

Rathore R, Pribil P, Corr JJ, Seibel WL, Evdokimov A, Greis KD.

J Biomol Screen. 2010 Sep;15(8):1001-7. doi: 10.1177/1087057110363824. Epub 2010 Mar 12.

PMID:
20228278
19.

Development of a dimethylarginine dimethylaminohydrolase (DDAH) assay for high-throughput chemical screening.

Ghebremariam YT, Erlanson DA, Yamada K, Cooke JP.

J Biomol Screen. 2012 Jun;17(5):651-61. doi: 10.1177/1087057112441521. Epub 2012 Mar 29.

20.

Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).

Schröter T, Minond D, Weiser A, Dao C, Habel J, Spicer T, Chase P, Baillargeon P, Scampavia L, Schürer S, Chung C, Mader C, Southern M, Tsinoremas N, LoGrasso P, Hodder P.

J Biomol Screen. 2008 Jan;13(1):17-28. doi: 10.1177/1087057107310806.

PMID:
18227223
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk